|
Volume
1 Number 1
January 2019
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
21, Year 2019 >
Number 1, January
|
|
|
|
|
|
|
|
Cojocaru
E, Mihăilă D, Leon-Constantin MM, Cobzaru RG, Rîpă
CV, Trandafirescu MF, Trandafir LM.
Update
in pediatric primary brain tumors - from histology to genetically
defined tumors.
Rom
J Morphol Embryol.
2019;60(3):761-767. ISSN (online) 2066–8279. _
|
|
|
|
Oltra-Sastre
M, Fuster-Garcia E, Juan-Albarracin J, Sáez C, Perez-Girbes
A, Sanz-Requena R, Revert-Ventura A, Mocholi A, Urchueguia J,
Hervas A, Reynes G, Font-de-Mora J, Muñoz-Langa J, Botella
C, Aparici F, Marti-Bonmati L, Garcia-Gomez JM.
Multi-parametric
MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas:
A Systematic Review.
Curr
Med Imaging Rev.
2019;15(10):933-947. doi: 10.2174/1573405615666190109100503; _
|
|
|
|
▲
|
|
AlRayahi J, Zapotocky M, Ramaswamy V, Hanagandi P, Branson H,
Mubarak W, Raybaud C, Laughlin S.
Pediatric Brain Tumor
Genetics: What Radiologists Need to Know.
Radiographics.
2018 Nov-Dec;38(7):2102-2122. doi: 10.1148/rg.2018180109.
_
|
|
|
|
Hegi ME, Kleihues P, Wen PY, Suvà ML.
Toward
methylation-based classification of central nervous system tumors.
Neuro
Oncol. 2018 Mar 23. 2018;20(5):579-581. doi:
10.1093/neuonc/noy023. _
|
|
|
|
Kessler AT, Bhatt AA.
Brain tumour post-treatment imaging
and treatment-related complications.
Insights
Imaging. 2018 Nov 8. 2018;9(6):1057-1075. doi:
10.1007/s13244-018-0661-y. _
|
|
|
|
Mirza FA, Shamim MS.
Tumour Treating Fields (TTFs) for
Paediatric Brain Tumours, Brain Metastases and other Novel
Applications.
J
Pak Med Assoc. 2018 Nov;68(11):1729-1731.
_
|
|
|
|
Tsang DS, Laperriere NJ.
Re-irradiation for Paediatric
Tumours.
Clin
Oncol (R Coll Radiol). 2018 Oct 29. doi:
10.1016/j.clon.2018.10.003. _
|
|
|
|
▲
|
|
Esparragosa I, Díez-Valle R, Tejada S, Gállego
Pérez-Larraya J.
Management of diffuse glioma.
Presse
Med. 2018 Oct 29. 2018;47(11-12 Pt 2):e199-e212.
doi: 10.1016/j.lpm.2018.04.014. _
|
|
|
|
Wesseling P, Capper D.
WHO 2016 Classification of gliomas.
Neuropathol
Appl Neurobiol. 2018 Feb 1. 2018;44(2):139-150.
doi: 10.1111/nan.12432. _
|
|
|
|
|
|
Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M.
Anti-angiogenic therapy for high-grade glioma.
Cochrane
Database Syst Rev. 2018 Nov 22;11:CD008218. doi:
10.1002/14651858.CD008218.pub4. _
|
|
|
|
Nayak L, Reardon DA.
High-grade Gliomas.
Continuum
(Minneap Minn). 2017 Dec 1. 2017;23(6):1548–1563.
doi: 10.1212/CON.0000000000000554. _
|
|
|
|
Noorlag L, De Vos FY, Kok A, Broekman MLD, Seute T, Robe PA,
Snijders TJ.
Treatment of malignant gliomas with
ketogenic or caloric restricted diets: A systematic review of
preclinical and early clinical studies.
Clin
Nutr. 2018 Nov 14. doi: 10.1016/j.clnu.2018.10.024.
_
|
|
|
|
|
|
Burak Atci I, Yilmaz H, Samanci MY.
The
top 50 most-cited articles on low-grade glioma: a bibliometric
analysis.
Br J
Neurosurg. 2019 Jan 12;33(2):171-175⍈.
doi: 10.1080/02688697.2018.1549314⍈.
PMID: 30636460⍈.
Bibliometric analysis. ⍈
|
|
|
|
Schiff D.
Low-grade
Gliomas.
Continuum
(Minneap Minn). 2017 Dec 1. 2017;23(6):1564–1579.
doi: 10.1212/CON.0000000000000537. _
|
|
|
|
▲
|
|
|
|
|
|
Gupta K, Burns TC.
Radiation-Induced Alterations in the
Recurrent Glioblastoma Microenvironment: Therapeutic Implications.
Front
Oncol. 2018 Nov 8;8:503. doi:
10.3389/fonc.2018.00503. _
|
|
|
|
Ludmir EB, Mandel JJ, McAleer MF, de Groot JF.
Disparities
along the glioblastoma clinical trials landscape.
Neuro
Oncol. 2018 Nov 26. doi: 10.1093/neuonc/noy176.
_
Comment
on: Vanderbeek AM, et al, The clinical trials landscape for
glioblastoma: is it adequate to develop new treatments?
Neuro
Oncol 5
April 2018. 20(8), 1034–1043,
2018 doi:10.1093/neuonc/noy027.
_
|
|
|
|
Michael JS, Lee BS, Zhang M, Yu JS.
Nanotechnology for
Treatment of Glioblastoma Multiforme.
J
Transl Int Med. 2018 Oct 9;6(3):128-133. doi:
10.2478/jtim-2018-0025. _
|
|
|
|
Wolf RL.
MRI of Recurrent Glioblastoma: Reliability and
Reality.
Radiology.
2018 Nov 27. 2019;290(2):477-478. doi: 10.1148/radiol.2018182530.
_
Comment
on: Barboriak DP
et
al, Interreader Variability of Dynamic Contrast-enhanced MRI of
Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625
Study. Radiology.
2018 Nov 27. 2019;290(2):467-476. doi: 10.1148/radiol.2019181296.
_
|
|
|
|
Zhang X, Ding K, Wang J, Li X, Zhao P.
Chemoresistance
caused by the microenvironment of glioblastoma and the
corresponding solutions.
Biomed
Pharmacother. 2018 Nov 2. 2019;109:39-46. doi:
10.1016/j.biopha.2018.10.063. _
|
|
|
|
|
|
Yoon GY, Oh HJ, Oh JS, Yoon SM, Bae HG.
Gliosarcoma of
Cerebello-Pontine Angle: A Case Report and Review of the
Literature.
Brain
Tumor Res Treat. 2018 Oct 30. 2018;6(2):78-81. doi:
10.14791/btrt.2018.6.e11.
_
|
|
|
|
▲
|
|
Karaconji T, Whist E, Jamieson RV, Flaherty MP, Grigg JRB.
Neurofibromatosis Type 1: Review and Update on Emerging
Therapies.
Asia
Pac J Ophthalmol (Phila). 2018 Nov 2. doi:
10.22608/APO.2018182. _
|
|
|
|
|
|
Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM.
Simpson-Golabi-Behmel Syndrome Type 1
In: Adam
MP, et al., eds. GeneReviews®.
Seattle (WA): University of Washington, Seattle; December 19,
2006. _
|
|
|
|
▲
|
|
|
